Credit: St. Michael's Hospital
A newly discovered bodily process in mice may explain why some human fetuses who have different antigens than their mothers suffer life-threatening brain bleeds, according to a new study.
"Antigens are like the body's national flag. They're planted on each cell in the body and tell the immune system whether something in the body, such as a bacteria or virus, is foreign," said Dr. Heyu Ni, a scientist in the Keenan Research Centre for Biomedical Science of St. Michael's Hospital. "Because each parent's DNA is different, a fetus can have different antigens, or flags, on some cells than his or her mom. When a mom's immune system identifies those cells as foreign to the body it attacks them, which can cause brain bleeds and result in neurological impairment or even death."
The condition where mothers and fetuses have different antigens is called fetal and neonatal alloimmune thrombocytopenia, or FNAIT. It affects about one in 1,000 live births. Fetuses experience bleeding in the brain in about 10 to 20 per cent of FNAIT cases. The disease can also cause miscarriages, although that has not been well studied.
Platelets—cells in the blood that help form blood clots and stop bleeding—are one of the cell types that commonly have different antigens. Because they are often different in the mother and fetus, they can be targeted by the mother's immune system. Until now, low amounts of platelets were considered the cause of brain bleeds in fetuses and newborns.
"Our research challenges the idea that low platelet counts are responsible for fetal brain bleeds and instead shows that the immune system's attack on the new blood vessel cells in the brain are more likely responsible," said Dr. Ni, who is also a Canadian Blood Services scientist. "An antigen, called beta 3 integrin, is found both on platelets and on the cells responsible for developing blood vessel in fetuses."
Newborn platelet levels are tested at birth since it's believed a lower platelet count signifies the newborn lacks the ability to stop bleeding. A safe level of platelets for newborns is between 150 million and 450 million cells per ml of blood. Babies with low platelet counts (less than 150 million cells per ml of blood) are usually treated right away with platelet transfusions.
"What we've discovered means that platelet transfusions are necessary to control bleeding after birth but may not be an effective therapy for brain bleeds in fetuses since platelets may be not essential to stop fetal bleeding," said Dr. Ni. "We should consider different therapies to prevent brain bleeds and ensure blood vessels in the brain are developed properly before birth."
Dr. Ni's research team also looked at the potential treatment of intravenous immunoglobulin transfusions. He said IVIG—made of plasma from donated blood—may be an effective therapy to control this devastating disease, although more research is needed to confirm this.
The study was published in the Journal of Clinical Investigation.
Explore further: Study finds traumatic brain injury treatment is ineffective
Medical Xpress on facebook
Related Stories
Researchers pinpoint possible new cause for unexplained miscarriages
Researchers at St. Michael's Hospital have identified a potential new cause for unexplained miscarriages in mice.
Potential new cause of miscarriage and habitual abortion
Fetal and neonatal immune thrombocytopenia (FNIT; aka FNAIT) is a condition in which fetuses and newborns have reduced numbers of blood cells known as platelets.
Study finds traumatic brain injury treatment is ineffective
More than 1.7 million people in the U.S. alone suffer a traumatic brain injury (TBI) every year, often resulting in permanent disabilities or death. Up to half of these patients will experience progression of bleeding inside ...
New treatments for blood clots on horizon
Researchers have made a discovery that could lead to new therapies for treating heart attack and stroke patients.
Protein in plasma may one day change transfusions
In injured mice, the naturally occurring protein fibronectin is instrumental in stopping bleeding but interestingly also at preventing life-threatening blood clots – according to new research published ...
Recommended for you
Scientists discover enzyme that keeps blood stem cells functional to prevent anemia
Stem cells can generate any type of cell in the body, but they are inactive most of the time—and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations. In ...
Researchers discover why drug for severe COPD becomes less effective
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results ...
Combination therapy boosts antiviral response to chronic infection
A Yale-led team has identified a promising new combination immunotherapy to enhance the body's ability to fight chronic viral infections and possibly cancer.
Biotechnologists develop gene therapy for erectile dysfunction
Erectile dysfunction is a taboo subject among men. No one likes to talk about it. But the fact is that as men age, an increasing number will suffer from erectile dysfunction. From the age of 30, the number ...
Researchers explore mechanism to stop ageing
As medicine has improved, we are increasing our ability to treat disease and improve longevity. The deterioration of the body with age, though, is a whole other matter.
New treatment for scaffold creates healthier engineered bladder tissue
A new technique to create tissue-engineered bladders has been shown to decrease scarring and significantly increase tissue growth. The bladders are produced using scaffolds coated with anti-inflammatory peptides. ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
Credit: St. Michael's Hospital
A newly discovered bodily process in mice may explain why some human fetuses who have different antigens than their mothers suffer life-threatening brain bleeds, according to a new study.
"Antigens are like the body's national flag. They're planted on each cell in the body and tell the immune system whether something in the body, such as a bacteria or virus, is foreign," said Dr. Heyu Ni, a scientist in the Keenan Research Centre for Biomedical Science of St. Michael's Hospital. "Because each parent's DNA is different, a fetus can have different antigens, or flags, on some cells than his or her mom. When a mom's immune system identifies those cells as foreign to the body it attacks them, which can cause brain bleeds and result in neurological impairment or even death."
The condition where mothers and fetuses have different antigens is called fetal and neonatal alloimmune thrombocytopenia, or FNAIT. It affects about one in 1,000 live births. Fetuses experience bleeding in the brain in about 10 to 20 per cent of FNAIT cases. The disease can also cause miscarriages, although that has not been well studied.
Platelets—cells in the blood that help form blood clots and stop bleeding—are one of the cell types that commonly have different antigens. Because they are often different in the mother and fetus, they can be targeted by the mother's immune system. Until now, low amounts of platelets were considered the cause of brain bleeds in fetuses and newborns.
"Our research challenges the idea that low platelet counts are responsible for fetal brain bleeds and instead shows that the immune system's attack on the new blood vessel cells in the brain are more likely responsible," said Dr. Ni, who is also a Canadian Blood Services scientist. "An antigen, called beta 3 integrin, is found both on platelets and on the cells responsible for developing blood vessel in fetuses."
Newborn platelet levels are tested at birth since it's believed a lower platelet count signifies the newborn lacks the ability to stop bleeding. A safe level of platelets for newborns is between 150 million and 450 million cells per ml of blood. Babies with low platelet counts (less than 150 million cells per ml of blood) are usually treated right away with platelet transfusions.
"What we've discovered means that platelet transfusions are necessary to control bleeding after birth but may not be an effective therapy for brain bleeds in fetuses since platelets may be not essential to stop fetal bleeding," said Dr. Ni. "We should consider different therapies to prevent brain bleeds and ensure blood vessels in the brain are developed properly before birth."
Dr. Ni's research team also looked at the potential treatment of intravenous immunoglobulin transfusions. He said IVIG—made of plasma from donated blood—may be an effective therapy to control this devastating disease, although more research is needed to confirm this.
The study was published in the Journal of Clinical Investigation.
Explore further: Study finds traumatic brain injury treatment is ineffective
Medical Xpress on facebook
Related Stories
Researchers pinpoint possible new cause for unexplained miscarriages
Researchers at St. Michael's Hospital have identified a potential new cause for unexplained miscarriages in mice.
Potential new cause of miscarriage and habitual abortion
Fetal and neonatal immune thrombocytopenia (FNIT; aka FNAIT) is a condition in which fetuses and newborns have reduced numbers of blood cells known as platelets.
Study finds traumatic brain injury treatment is ineffective
More than 1.7 million people in the U.S. alone suffer a traumatic brain injury (TBI) every year, often resulting in permanent disabilities or death. Up to half of these patients will experience progression of bleeding inside ...
New treatments for blood clots on horizon
Researchers have made a discovery that could lead to new therapies for treating heart attack and stroke patients.
Protein in plasma may one day change transfusions
In injured mice, the naturally occurring protein fibronectin is instrumental in stopping bleeding but interestingly also at preventing life-threatening blood clots – according to new research published ...
Recommended for you
Scientists discover enzyme that keeps blood stem cells functional to prevent anemia
Stem cells can generate any type of cell in the body, but they are inactive most of the time—and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations. In ...
Researchers discover why drug for severe COPD becomes less effective
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results ...
Combination therapy boosts antiviral response to chronic infection
A Yale-led team has identified a promising new combination immunotherapy to enhance the body's ability to fight chronic viral infections and possibly cancer.
Biotechnologists develop gene therapy for erectile dysfunction
Erectile dysfunction is a taboo subject among men. No one likes to talk about it. But the fact is that as men age, an increasing number will suffer from erectile dysfunction. From the age of 30, the number ...
Researchers explore mechanism to stop ageing
As medicine has improved, we are increasing our ability to treat disease and improve longevity. The deterioration of the body with age, though, is a whole other matter.
New treatment for scaffold creates healthier engineered bladder tissue
A new technique to create tissue-engineered bladders has been shown to decrease scarring and significantly increase tissue growth. The bladders are produced using scaffolds coated with anti-inflammatory peptides. ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment